LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas to participate in panel discussion on "The Impact of Globalization in Healthcare" at the North Carolina Biotechnology Center.
News | 08. 15. 2006
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.